Statins have been found to cut death from infections that cause illnesses such as pneumonia by a third, which could lead to even more people being prescribed the so–called wonder drugs. The Daily Telegraph reported today that up to seven million people in Britain take the cholesterol–lowering medication, which can save lives by reducing the chances of suffering a heart attack or stroke. But \"unexpected\" findings from British researchers suggest that statins\' principal long–term benefit is stopping deaths from infections and respiratory illness. It could mean that patients at higher risk of developing pneumonia could also be prescribed the drugs, despite a fear that too many \"worried well\" already take statins, which cost about £500million a year. A study in The Lancet last month suggested some people taking the drugs were unlikely to gain any benefit. Prof Peter Sever, from Imperial College London\'s international centre for circulatory health, said of the latest findings: \"This result is very unexpected. The benefits of statins for preventing heart attacks and strokes are well established, but after long–term follow–up the most significant effects seem to be on deaths from other causes.\" There was now \"an emerging evidence base for statins protecting against infections\", said Prof Sever, who presented the results yesterday at the annual congress of the European Society of Cardiology in Paris. A paper has also been published in the European Heart Journal.